eurekalert.org
Crohn's & Colitis Congress® spotlights key IBD research findings
This roundup highlights new IBD research and real-world care issues that could influence future diagnosis, monitoring, and access to treatments. Findings on financial barriers and gaps in treat-to-target monitoring may affect patients' ability to get and stay on recommended care.
Early-stage studies (epigenetics, device patches, diet trials) point to possible future tools but are not immediate treatment changes.
People with IBD and their caregivers, clinicians who treat IBD, and researchers following IBD genetics, biomarkers, or digital monitoring technologies.
What To Know
This press release previews research presented at the Crohn’s & Colitis Congress (Feb 6–8, 2025). It summarizes multiple abstracts and studies, including a survey on financial barriers to care, an epigenetics study identifying DNA methylation sites in low-genetic-risk Crohn’s patients, and a treat-to-target adherence analysis using IBD Qorus data.
It also notes abstracts on wireless monitoring patches, dietary therapy in children, and online trial recruitment. The release points readers to the full abstract book and to contact emails for media inquiries. The article is an event preview summarizing many early or conference-presented findings rather than reporting full peer-reviewed results.
Key topics include access and cost barriers (insurance, step therapy), epigenetic research using IBD Plexus data, and real-world gaps in completing treat-to-target monitoring (endoscopy and fecal calprotectin).
The release states that abstracts will be published in supplements to Gastroenterology and Inflammatory Bowel Diseases and that data were embargoed until the meeting start.
If you want details: look for the individual abstracts or subsequent peer-reviewed papers; the press release provides contact emails and says all abstracts are available through the meeting and journal supplements.
This is a conference preview summarizing multiple abstracts and survey results; details, methods, and full data are not reported here. Abstracts are embargoed until the meeting and will be published as supplements—read those original abstracts or later peer-reviewed papers for full methods and results.
